MyAverix Finance
TWO · Healthcare
Mercury Biopharmaceutical Corporation (6932)
Drug Manufacturers - Specialty & Generic
Mercury Biopharmaceutical Corporation (6932) is listed on TWO in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 6932
Mercury Biopharmaceutical Corporation (6932) — FAQ
What is 6932's P/E ratio?
The price-to-earnings (P/E) ratio for Mercury Biopharmaceutical Corporation (6932) is 18.00 (data as of 2026-03-23).
Does Mercury Biopharmaceutical Corporation pay a dividend?
Dividend yield is not available in the current snapshot for Mercury Biopharmaceutical Corporation (6932). Check the MyAverix Finance app for the latest dividend data.
What sector is Mercury Biopharmaceutical Corporation in?
Mercury Biopharmaceutical Corporation (6932) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 6932 listed on?
6932 is listed on TWO.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.